The Relationship Between Exercise Frequency, Intensity, and Restoration of Cardiometabolic Health
1 other identifier
interventional
23
1 country
1
Brief Summary
Regular physical activity is well established to decrease the risk of cardiometabolic diseases. While research has characterized responses based on exercise intensity, many beneficial effects of exercise are transient in nature, and therefore exercise frequency may play an important, yet currently under-appreciated, role in improving health. The purpose of this study is to determine the efficacy of 6-week high-frequency endurance (END) or low-frequency sprint (SIT) training with respect to reducing clinically relevant cardiometabolic risk factors in overweight/obese males. It is hypothesized that END, performed at a greater frequency than SIT, will markedly improve cardiometabolic health, while low-frequency SIT will not.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2017
CompletedFirst Posted
Study publicly available on registry
December 18, 2017
CompletedStudy Start
First participant enrolled
May 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 18, 2019
CompletedApril 29, 2020
April 1, 2020
1.5 years
December 6, 2017
April 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cardiorespiratory fitness
Assessed via VO2 peak test, to determine the change in cardiorespiratory fitness following 6-weeks of exercise training
Baseline (pre-training) vs. week 6 (post-training)
Free-living glycemic regulation
Assessed via continuous glucose monitoring (CGM), to determine the change in free-living glycemic regulation following 6-weeks of exercise training
Baseline (pre-training) vs. week 6 (post-training)
Glucose tolerance
Assessed via an oral glucose tolerance test (OGTT) to determine changes in standardized glycemic regulation following 6-weeks of exercise training
Baseline (pre-training) vs. week 6 (post-training)
Secondary Outcomes (11)
Blood lipids
Baseline (pre-training) vs. week 6 (post-training)
HbA1C
Baseline (pre-training) vs. week 6 (post-training)
Post-prandial blood lipids
Baseline (pre-training) vs. week 6 (post-training)
Blood pressure
Baseline (pre-training) vs. week 6 (post-training)
Body composition
Baseline (pre-training) vs. week 6 (post-training)
- +6 more secondary outcomes
Study Arms (2)
Endurance Exercise Training (END)
EXPERIMENTALThis group is performing END training for 6 weeks in duration. Intervention: Behavioral: Endurance Exercise Training (END)
Sprint Exercise Training (SIT)
EXPERIMENTALThis group is performing SIT training for 6 weeks in duration. Intervention: Behavioral: Sprint Exercise Training (SIT)
Interventions
Physical activity will be conducted on cycle ergometers under supervision. Participants will exercise 5 days a week for 30 minutes (Week 1-2); 35 minutes (Weeks 3-4); or 40 minutes (Weeks 5-6) at 60% VO2 peak.
Physical activity will be conducted on cycle ergometers under supervision. Participants will exercise 3 days a week involving a 3-minute warm-up, followed up 4 repetitions (Week 1-2); 5 repetitions (Weeks 3-4); or 6 (Weeks 5-6) repetitions of 30 seconds at a maximal intensity with 2 minutes' rest in between. Exercise will conclude with a 2-minute cool-down.
Eligibility Criteria
You may qualify if:
- Male, aged 18-70 years
- Body mass index (BMI) \> 25 kg/m\^2 (classified as overweight or obese)
- Sedentary (\<100 minutes moderate physical activity per week)
- Approval for vigorous exercise via physical activity readiness questionnaire (PARQ+)
You may not qualify if:
- Prescribed with glucose lowering medications
- Smoker
- Not cleared for physical activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Guelph
Guelph, Ontario, N1G 2W1, Canada
Related Publications (1)
Petrick HL, King TJ, Pignanelli C, Vanderlinde TE, Cohen JN, Holloway GP, Burr JF. Endurance and Sprint Training Improve Glycemia and V O2peak but only Frequent Endurance Benefits Blood Pressure and Lipidemia. Med Sci Sports Exerc. 2021 Jun 1;53(6):1194-1205. doi: 10.1249/MSS.0000000000002582.
PMID: 33315809DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jamie Burr, PhD
University of Guelph
- PRINCIPAL INVESTIGATOR
Graham Holloway, PhD
University of Guelph
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Jamie Burr, Director, Human Performance and Health Laboratory, Principal Investigator, Assistant Professor, PhD
Study Record Dates
First Submitted
December 6, 2017
First Posted
December 18, 2017
Study Start
May 30, 2018
Primary Completion
November 18, 2019
Study Completion
November 18, 2019
Last Updated
April 29, 2020
Record last verified: 2020-04